ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 182 filers reported holding ASCENDIS PHARMA A/S in Q1 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,223,334 | +54.1% | 109,177 | +46.9% | 0.01% | +166.7% |
| Q2 2023 | $6,633,061 | -26.1% | 74,320 | -11.2% | 0.00% | -57.1% |
| Q1 2023 | $8,973,027 | +9.4% | 83,688 | +24.6% | 0.01% | +16.7% |
| Q4 2022 | $8,204,082 | +6115.2% | 67,175 | +5152.2% | 0.01% | – |
| Q3 2022 | $132,000 | -11.4% | 1,279 | -19.9% | 0.00% | – |
| Q2 2022 | $149,000 | -33.2% | 1,597 | -16.1% | 0.00% | – |
| Q1 2022 | $223,000 | -32.0% | 1,903 | -21.9% | 0.00% | – |
| Q4 2021 | $328,000 | -42.0% | 2,437 | -31.3% | 0.00% | – |
| Q3 2021 | $566,000 | +14.8% | 3,548 | -5.3% | 0.00% | – |
| Q2 2021 | $493,000 | +185.0% | 3,748 | +179.7% | 0.00% | – |
| Q1 2021 | $173,000 | -44.6% | 1,340 | -28.4% | 0.00% | – |
| Q4 2020 | $312,000 | -26.9% | 1,871 | -32.4% | 0.00% | – |
| Q3 2020 | $427,000 | -10.9% | 2,769 | -14.6% | 0.00% | – |
| Q2 2020 | $479,000 | +51.1% | 3,241 | +15.0% | 0.00% | – |
| Q1 2020 | $317,000 | -36.0% | 2,819 | -20.7% | 0.00% | – |
| Q4 2019 | $495,000 | +326.7% | 3,555 | +196.0% | 0.00% | – |
| Q3 2019 | $116,000 | -4.1% | 1,201 | +14.7% | 0.00% | – |
| Q2 2019 | $121,000 | +72.9% | 1,047 | +76.6% | 0.00% | – |
| Q1 2019 | $70,000 | +677.8% | 593 | +317.6% | 0.00% | – |
| Q1 2018 | $9,000 | -78.6% | 142 | -86.4% | 0.00% | – |
| Q4 2017 | $42,000 | +4100.0% | 1,044 | +1988.0% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 50 | +19.0% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 42 | -47.5% | 0.00% | – |
| Q1 2015 | $1,000 | – | 80 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |